Business Description
AbbVie Inc
NAICS : 325412
SIC : 5122
ISIN : US00287Y1091
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 5.73 | |||||
Debt-to-EBITDA | 3.46 | |||||
Interest Coverage | 6.09 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.01 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | 9.6 | |||||
3-Year EPS without NRI Growth Rate | 49.1 | |||||
3-Year FCF Growth Rate | 7.4 | |||||
3-Year Book Growth Rate | -7.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 6.34 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.5 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.19 | |||||
9-Day RSI | 52.51 | |||||
14-Day RSI | 47.55 | |||||
6-1 Month Momentum % | 21.97 | |||||
12-1 Month Momentum % | 8.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.87 | |||||
Quick Ratio | 0.76 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 69.9 | |||||
Days Sales Outstanding | 76.32 | |||||
Days Payable | 59.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.57 | |||||
Dividend Payout Ratio | 0.67 | |||||
3-Year Dividend Growth Rate | 7.8 | |||||
Forward Dividend Yield % | 3.66 | |||||
5-Year Yield-on-Cost % | 5.83 | |||||
Shareholder Yield % | 7.23 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.42 | |||||
Operating Margin % | 24.92 | |||||
Net Margin % | 8.95 | |||||
FCF Margin % | 40.62 | |||||
ROE % | 36.93 | |||||
ROA % | 3.58 | |||||
ROIC % | 9.52 | |||||
ROC (Joel Greenblatt) % | 171.32 | |||||
ROCE % | 8.18 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 61.47 | |||||
Forward PE Ratio | 15 | |||||
PE Ratio without NRI | 18.93 | |||||
Shiller PE Ratio | 37.12 | |||||
Price-to-Owner-Earnings | 23.28 | |||||
PEG Ratio | 1.22 | |||||
PS Ratio | 5.51 | |||||
PB Ratio | 28.59 | |||||
Price-to-Free-Cash-Flow | 13.59 | |||||
Price-to-Operating-Cash-Flow | 13.12 | |||||
EV-to-EBIT | 40.92 | |||||
EV-to-Forward-EBIT | 13.76 | |||||
EV-to-EBITDA | 20.19 | |||||
EV-to-Forward-EBITDA | 13.22 | |||||
EV-to-Revenue | 6.38 | |||||
EV-to-Forward-Revenue | 6.36 | |||||
EV-to-FCF | 15.72 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Price-to-DCF (Earnings Based) | 0.85 | |||||
Price-to-DCF (FCF Based) | 0.44 | |||||
Price-to-Median-PS-Value | 1.25 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.92 | |||||
Earnings Yield (Greenblatt) % | 2.44 | |||||
FCF Yield % | 7.43 | |||||
Forward Rate of Return (Yacktman) % | 26.65 |